regulated by the efflux transport system in the blood–brain barrier.
Life Sci. 66, 649–662.
Feng B., Dresser M. J., Shu Y., Johns S. J. and Giacomini K. M. (2001)
Arginine 454 and lysine 370 are essential for the anion specificity of
the organic anion transporter, rOAT3. Biochemistry 40, 5511–5520.
Feng B., Shu Y. and Giacomini K. M. (2002) Role of aromatic transmembrane residues of the organic anion transporter, rOAT3, in
substrate recognition. Biochemistry 41, 8941–8947.
Hagenbuch B. and Meier P. J. (2003) The superfamily of organic anion
transporting polypeptides. Biochim. Biophys. Acta 1609, 1–18.
Hasegawa H., Allen J. C., Mehta B. M., Shapiro W. R. and Posner J. B.
(1979) Enhancement of CNS penetration of methotrexate by
hyperosmolar intracarotid mannitol or carcinomatous meningitis.
Neurology 29, 1280–1286.
Hosoya K., Ohtsuki S. and Terasaki T. (2002) Recent advances in the
brain-to-blood efflux transport across the blood–brain barrier. Int.
J. Pharm. 248, 15–29.
Isakovic A. J., Segal M. B., Milojkovic B. A., Dacevic M. P., Misirlic S. T.,
Rakic M. L. and Redzic Z. B. (2002) The efflux of purine nucleobases and nucleosides from the rat brain. Neurosci. Lett. 318, 65–68.
Jacqz-Aigrain E., Nafa S., Me ́dard Y., Bessa E., Lescoeur B. and Vilmer E.
(1997) Pharmacokinetics and distribution of 6-mercaptopurine
administered intravenously in children with lymphoblastic leukaemia. Eur. J. Clin. Pharmacol. 53, 71–74.
Jedlitschky G., Burchell B. and Keppler D. (2000) The multidrug
resistance protein 5 functions as an ATP-dependent export pump
for cyclic nucleotides. J. Biol. Chem. 275, 30069–30074.
Kakee A., Terasaki T. and Sugiyama Y. (1996) Brain efflux index as a
novel method of analyzing efflux transport at the blood–brain
barrier. J. Pharmacol. Exp. Ther. 277, 1550–1559.
Kekuda R., Prasad P. D., Wu X., Wang H., Fei Y. J., Leibach F. H. and
Ganapathy V. (1998) Cloning and functional characterization of a
potential-sensitive, polyspecific organic cation transporter (OCT3)
most abundantly expressed in placenta. J. Biol. Chem. 273, 15971–
15979.
Kikuchi R., Kusuhara H., Sugiyama D. and Sugiyama Y. (2003) Contribution of organic anion transporter 3 (Slc22a8) to the elimination
of p-aminohippuric acid and benzylpenicillin across the blood–
brain barrier. J. Pharmacol. Exp. Ther. 306, 51–58.
Kusuhara H., Sekine T., Utsunomiya-Tate N., Tsuda M., Kojima R.,
Cha S. H., Sugiyama Y., Kanai Y. and Endou H. (1999) Molecular
cloning and characterization of a new multispecific organic anion
transporter from rat brain. J. Biol. Chem. 274, 13675–13680.
Lowe E. S., Kitchen B. J., Erdmann G. et al. (2001) Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in
children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study.
Cancer Chemother. Pharmacol. 47, 199–205.
Miller D. S., Nobmann S. N., Gutmann H., Toeroek M., Drewe J. and
Fricker G. (2000) Xenobiotic transport across isolated brain
microvessels studied by confocal microscopy. Mol. Pharmacol. 58,
1357–1367.
Millot F., Rubie H., Mazingue F., Mechinaud F. and Thyss A.
(1994) Cerebrospinal fluid drug levels of leukemic children
receiving intravenous 5 g/m2 methotrexate. Leuk. Lymphoma 14,
141–144.
Mori S., Takanaga H., Ohtsuki S., Deguchi T., Kang Y. S., Hosoya K.
and Terasaki T. (2003) Rat organic anion transporter 3 (rOAT3) is
responsible for brain-to-blood efflux of homovanillic acid at the
abluminal membrane of brain capillary endothelial cells. J. Cereb.
Blood Flow Metab. 23, 432–440.
Nagata Y., Kusuhara H., Endou H. and Sugiyama Y. (2002) Expression
and functional characterization of rat organic anion transporter 3
(rOat3) in the choroid plexus. Mol. Pharmacol. 61, 982–988.
